Recent News

May 5, 2021

Catalyst OrthoScience Announces First Surgeries Using Archer™ R1 Reverse Shoulder System

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.
April 28, 2021

Catalyst OrthoScience Gains Momentum As It Introduces The Archer™ R1 Reverse Shoulder System And Rebrands Its Archer™ CSR Total Shoulder System

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.
March 17, 2021

Catalyst OrthoScience Receives FDA 510(k) Clearance Of Its Reverse Shoulder System

Catalyst OrthoScience has received clearance from the U.S. Food & Drug Administration to market its reverse shoulder system. Catalyst expects to begin a limited user release in the United States in the second quarter of 2021 followed by a commercial launch later in 2021.
February 17, 2021

Newly Published Study With The Stemless Catalyst CSR™ Total Shoulder System Demonstrates Good Results In Adult Arthroplasty Patients Of All Ages At 2-3 Year Follow-Up

Published peer reviewed study show significant improvements in motion and patient-reported measures in adult shoulder replacement patients of all ages.
January 27, 2021

Catalyst In The News: Hand and Upper Limb Orthopedic Surgeon Dr. Badia Says Partial Shoulder Reconstruction Option for More Patients and Ideal for Outpatient Surgery; Offers Tips

October 14, 2020

Virtual Reality Brings The Future Of Shoulder Arthroplasty To Surgeons With Catalyst OrthoScience, Immertec Technologies

With the ongoing pandemic affecting in-person meetings and travel, two companies worked to bring surgeon training into the future using virtual reality (VR). Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, presented a training lab for surgeons across the country using Immertec’s proprietary VR platform Medoptic.
October 17, 2019

Catalyst OrthoScience Features Two New Products, William Levine, MD Presents The Catalyst CSR™ Total Shoulder System at ASES 2019 Annual Meeting

William Levine, MD presents the Catalyst CSR™ Total Shoulder System, including two new components, during the 2019 ASES meeting on Saturday, Oct. 19.
May 14, 2019

Catalyst OrthoScience Closes $12.7 Million Oversubscribed Financing Round to Fuel Growth of Novel Total Shoulder System

Catalyst OrthoScience has raised $12.7 million in an oversubscribed Series C-1 financing round led by River Cities Capital Funds.
May 9, 2019

New Study Shows Catalyst CSR™ Total Shoulder System Provides Improved Accuracy and Precision in Restoring Humeral Anatomy

Catalyst OrthoScience announced the publication of a peer-reviewed study in the Journal of Shoulder and Elbow Arthroplasty
March 13, 2019

Catalyst Orthoscience Announces 510(k) Clearance for Uncemented Press Fit Humeral Component

Catalyst OrthoScience announced 510(k) clearance for its uncemented Press Fit humeral implant. The new humeral